Table 2.
Correlation Analyses of FKBP5 CpG‐3 Methylation and Other Parameters in Patients With Dilated Cardiomyopathy
| Factors | FKBP5 CpG‐3 methylation | |
|---|---|---|
| r | P value | |
| Age, y | 0.180 | 0.333 |
| Male participants (0=no, 1=yes) | 0.117 | 0.359 |
| Body mass index, kg/m2 | −0.255 | 0.174 |
| Laboratory data | ||
| White blood cell, ×103/μL | −0.229 | 0.223 |
| Hemoglobin, g/dL | −0.321 | 0.110 |
| Platelet, ×103/μL | −0.160 | 0.417 |
| Aspartate aminotransferase, U/L | −0.018 | 0.923 |
| Alanine transaminase, U/L | −0.284 | 0.122 |
| Albumin, g/dL | −0.177 | 0.430 |
| Creatinine, mg/dL | 0.153 | 0.410 |
| Hemoglobin A1c, % | 0.074 | 0.802 |
| Uric acid, mg/dL | −0.203 | 0.390 |
| Low‐density lipoprotein cholesterol, mg/dL | −0.299 | 0.299 |
| C‐reactive protein, mg/dL | 0.208 | 0.289 |
| B‐type natriuretic peptide, pg/mL | −0.029 | 0.875 |
| Troponin I, ng/mL | 0.185 | 0.337 |
| Echocardiography | ||
| Left ventricular end‐diastolic dimension, mm | 0.018 | 0.930 |
| Left ventricular ejection fraction, % | −0.020 | 0.913 |
CpG indicates cytosine‐phosphate‐guaninea and FKBP5, FKBP prolyl isomerase 5.